These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3544820)
1. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial. Valeri A; Gelfand J; Blum C; Appel GB Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820 [TBL] [Abstract][Full Text] [Related]
2. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy. Dujovne CA; Krehbiel P; Chernoff SB Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176 [TBL] [Abstract][Full Text] [Related]
3. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754 [TBL] [Abstract][Full Text] [Related]
4. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Glueck CJ Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445 [TBL] [Abstract][Full Text] [Related]
5. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. Kuo PT; Wilson AC; Kostis JB; Moreyra AE Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177 [TBL] [Abstract][Full Text] [Related]
6. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia. Schonfeld G; Witztum J; Basich P Artery; 1982; 10(2):99-104. PubMed ID: 7092583 [TBL] [Abstract][Full Text] [Related]
7. Probucol with colestipol in the treatment of hypercholesterolemia. Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578 [TBL] [Abstract][Full Text] [Related]
8. Low-dose colestipol plus probucol for hypercholesterolemia. Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337 [TBL] [Abstract][Full Text] [Related]
9. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome. Iida H; Izumino K; Asaka M; Fujita M; Nishino A; Sasayama S Nephron; 1987; 47(4):280-3. PubMed ID: 3696330 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein fractions and receptors: a role for probucol? Bilheimer DW Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051 [TBL] [Abstract][Full Text] [Related]
11. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013 [TBL] [Abstract][Full Text] [Related]
12. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. Illingworth DR Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462 [TBL] [Abstract][Full Text] [Related]
13. Mode of hypocholesterolemic action of probucol in animals and man. Beynen AC Artery; 1987; 14(2):113-26. PubMed ID: 3551883 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group. Olbricht CJ; Wanner C; Thiery J; Basten A Kidney Int Suppl; 1999 Jul; 71():S113-6. PubMed ID: 10412752 [TBL] [Abstract][Full Text] [Related]
15. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
16. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia. Davis TA; Anderson EC; Ginsburg AV; Goldberg AP J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301 [TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923 [TBL] [Abstract][Full Text] [Related]
18. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081 [TBL] [Abstract][Full Text] [Related]
19. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia. Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586 [TBL] [Abstract][Full Text] [Related]
20. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]